High BRCAness was associated significantly with triple-negative breast cancer (TNBC) and higher pathological grade, and good response to chemotherapy and PARP inhibitor in both ER-positive/HER2-negative breast cancer and TNBC. The gene discussed is ERBB2; the disease is breast cancer.